世界の片肢性骨端異形成症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dysplasia Epiphysealis Hemimelica Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4166
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、片肢性骨端異形成症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（股関節置換術、膝関節置換術、関節温存式腫瘤切除手術）、用途別市場規模（病院、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・片肢性骨端異形成症治療の市場動向
・企業の競争状況、市場シェア
・片肢性骨端異形成症治療の種類別市場規模と予測2016-2027（股関節置換術、膝関節置換術、関節温存式腫瘤切除手術）
・片肢性骨端異形成症治療の用途別市場規模と予測2016-2027（病院、外来外科センター、その他）
・片肢性骨端異形成症治療の北米市場規模2016-2027（アメリカ、カナダ）
・片肢性骨端異形成症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・片肢性骨端異形成症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・片肢性骨端異形成症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・片肢性骨端異形成症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Zimmer Biomet、AstraZeneca、Genentech、Pfizer、Johnson&Johnson、Novartis、Teva、Medacta）
・結論

Dysplasia epiphysealis hemimelica (DEH), commonly known as Trevor disease, is a rare non-hereditary epiphyseal disorder, which is characterized by localized overgrowth of osteochondral affecting one or more ossification centers or epiphyses.

Market Analysis and Insights: Global Dysplasia Epiphysealis Hemimelica Treatment Market
The global Dysplasia Epiphysealis Hemimelica Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dysplasia Epiphysealis Hemimelica Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dysplasia Epiphysealis Hemimelica Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dysplasia Epiphysealis Hemimelica Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dysplasia Epiphysealis Hemimelica Treatment market.

Global Dysplasia Epiphysealis Hemimelica Treatment Scope and Market Size
Dysplasia Epiphysealis Hemimelica Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dysplasia Epiphysealis Hemimelica Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hip Replacement Surgery
Knee Replacement Surgery
Surgical Excision of Mass with Preservation of the Joint

Segment by Application
Hospital
Ambulatory Surgical Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Zimmer Biomet
AstraZeneca
Genentech
Pfizer
Johnson&Johnson
Novartis
Teva
Medacta

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dysplasia Epiphysealis Hemimelica Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hip Replacement Surgery
1.2.3 Knee Replacement Surgery
1.2.4 Surgical Excision of Mass with Preservation of the Joint
1.3 Market by Application
1.3.1 Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dysplasia Epiphysealis Hemimelica Treatment Market Perspective (2016-2027)
2.2 Dysplasia Epiphysealis Hemimelica Treatment Growth Trends by Regions
2.2.1 Dysplasia Epiphysealis Hemimelica Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dysplasia Epiphysealis Hemimelica Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dysplasia Epiphysealis Hemimelica Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dysplasia Epiphysealis Hemimelica Treatment Industry Dynamic
2.3.1 Dysplasia Epiphysealis Hemimelica Treatment Market Trends
2.3.2 Dysplasia Epiphysealis Hemimelica Treatment Market Drivers
2.3.3 Dysplasia Epiphysealis Hemimelica Treatment Market Challenges
2.3.4 Dysplasia Epiphysealis Hemimelica Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dysplasia Epiphysealis Hemimelica Treatment Players by Revenue
3.1.1 Global Top Dysplasia Epiphysealis Hemimelica Treatment Players by Revenue (2016-2021)
3.1.2 Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dysplasia Epiphysealis Hemimelica Treatment Revenue
3.4 Global Dysplasia Epiphysealis Hemimelica Treatment Market Concentration Ratio
3.4.1 Global Dysplasia Epiphysealis Hemimelica Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dysplasia Epiphysealis Hemimelica Treatment Revenue in 2020
3.5 Dysplasia Epiphysealis Hemimelica Treatment Key Players Head office and Area Served
3.6 Key Players Dysplasia Epiphysealis Hemimelica Treatment Product Solution and Service
3.7 Date of Enter into Dysplasia Epiphysealis Hemimelica Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dysplasia Epiphysealis Hemimelica Treatment Breakdown Data by Type
4.1 Global Dysplasia Epiphysealis Hemimelica Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dysplasia Epiphysealis Hemimelica Treatment Forecasted Market Size by Type (2022-2027)

5 Dysplasia Epiphysealis Hemimelica Treatment Breakdown Data by Application
5.1 Global Dysplasia Epiphysealis Hemimelica Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dysplasia Epiphysealis Hemimelica Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size (2016-2027)
6.2 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type
6.2.1 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021)
6.2.2 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027)
6.2.3 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2027)
6.3 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application
6.3.1 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021)
6.3.2 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027)
6.3.3 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2027)
6.4 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country
6.4.1 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021)
6.4.2 North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size (2016-2027)
7.2 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type
7.2.1 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2027)
7.3 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application
7.3.1 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2027)
7.4 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country
7.4.1 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type
8.2.1 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application
8.3.1 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Region
8.4.1 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size (2016-2027)
9.2 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type
9.2.1 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2027)
9.3 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application
9.3.1 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2027)
9.4 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country
9.4.1 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type
10.2.1 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application
10.3.1 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country
10.4.1 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Zimmer Biomet
11.1.1 Zimmer Biomet Company Details
11.1.2 Zimmer Biomet Business Overview
11.1.3 Zimmer Biomet Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.1.4 Zimmer Biomet Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.1.5 Zimmer Biomet Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.2.4 AstraZeneca Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Genentech
11.3.1 Genentech Company Details
11.3.2 Genentech Business Overview
11.3.3 Genentech Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.3.4 Genentech Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.3.5 Genentech Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.4.4 Pfizer Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Johnson&Johnson
11.5.1 Johnson&Johnson Company Details
11.5.2 Johnson&Johnson Business Overview
11.5.3 Johnson&Johnson Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.5.4 Johnson&Johnson Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.5.5 Johnson&Johnson Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.6.4 Novartis Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.7.4 Teva Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.7.5 Teva Recent Development
11.8 Medacta
11.8.1 Medacta Company Details
11.8.2 Medacta Business Overview
11.8.3 Medacta Dysplasia Epiphysealis Hemimelica Treatment Introduction
11.8.4 Medacta Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
11.8.5 Medacta Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hip Replacement Surgery
Table 3. Key Players of Knee Replacement Surgery
Table 4. Key Players of Surgical Excision of Mass with Preservation of the Joint
Table 5. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Regions (2016-2021)
Table 9. Global Dysplasia Epiphysealis Hemimelica Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Regions (2022-2027)
Table 11. Dysplasia Epiphysealis Hemimelica Treatment Market Trends
Table 12. Dysplasia Epiphysealis Hemimelica Treatment Market Drivers
Table 13. Dysplasia Epiphysealis Hemimelica Treatment Market Challenges
Table 14. Dysplasia Epiphysealis Hemimelica Treatment Market Restraints
Table 15. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Players (2016-2021)
Table 17. Global Top Dysplasia Epiphysealis Hemimelica Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dysplasia Epiphysealis Hemimelica Treatment as of 2020)
Table 18. Ranking of Global Top Dysplasia Epiphysealis Hemimelica Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Dysplasia Epiphysealis Hemimelica Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dysplasia Epiphysealis Hemimelica Treatment Product Solution and Service
Table 22. Date of Enter into Dysplasia Epiphysealis Hemimelica Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Dysplasia Epiphysealis Hemimelica Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Dysplasia Epiphysealis Hemimelica Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Zimmer Biomet Company Details
Table 63. Zimmer Biomet Business Overview
Table 64. Zimmer Biomet Dysplasia Epiphysealis Hemimelica Treatment Product
Table 65. Zimmer Biomet Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 66. Zimmer Biomet Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Dysplasia Epiphysealis Hemimelica Treatment Product
Table 70. AstraZeneca Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Genentech Company Details
Table 73. Genentech Business Overview
Table 74. Genentech Dysplasia Epiphysealis Hemimelica Treatment Product
Table 75. Genentech Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 76. Genentech Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Dysplasia Epiphysealis Hemimelica Treatment Product
Table 80. Pfizer Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Johnson&Johnson Company Details
Table 83. Johnson&Johnson Business Overview
Table 84. Johnson&Johnson Dysplasia Epiphysealis Hemimelica Treatment Product
Table 85. Johnson&Johnson Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 86. Johnson&Johnson Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Dysplasia Epiphysealis Hemimelica Treatment Product
Table 90. Novartis Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Teva Company Details
Table 93. Teva Business Overview
Table 94. Teva Dysplasia Epiphysealis Hemimelica Treatment Product
Table 95. Teva Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 96. Teva Recent Development
Table 97. Medacta Company Details
Table 98. Medacta Business Overview
Table 99. Medacta Revenue in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021) & (US$ Million)
Table 100. Medacta Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hip Replacement Surgery Features
Figure 3. Knee Replacement Surgery Features
Figure 4. Surgical Excision of Mass with Preservation of the Joint Features
Figure 5. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Ambulatory Surgical Center Case Studies
Figure 8. Others Case Studies
Figure 9. Dysplasia Epiphysealis Hemimelica Treatment Report Years Considered
Figure 10. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Dysplasia Epiphysealis Hemimelica Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Regions (2022-2027)
Figure 14. Global Dysplasia Epiphysealis Hemimelica Treatment Market Share by Players in 2020
Figure 15. Global Top Dysplasia Epiphysealis Hemimelica Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dysplasia Epiphysealis Hemimelica Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Dysplasia Epiphysealis Hemimelica Treatment Revenue in 2020
Figure 17. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Dysplasia Epiphysealis Hemimelica Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Dysplasia Epiphysealis Hemimelica Treatment Market Share by Type (2016-2027)
Figure 21. North America Dysplasia Epiphysealis Hemimelica Treatment Market Share by Application (2016-2027)
Figure 22. North America Dysplasia Epiphysealis Hemimelica Treatment Market Share by Country (2016-2027)
Figure 23. United States Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Share by Type (2016-2027)
Figure 27. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Share by Application (2016-2027)
Figure 28. Europe Dysplasia Epiphysealis Hemimelica Treatment Market Share by Country (2016-2027)
Figure 29. Germany Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Dysplasia Epiphysealis Hemimelica Treatment Market Share by Region (2016-2027)
Figure 39. China Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Dysplasia Epiphysealis Hemimelica Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Dysplasia Epiphysealis Hemimelica Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Dysplasia Epiphysealis Hemimelica Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Zimmer Biomet Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 60. Genentech Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 62. Johnson&Johnson Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 65. Medacta Revenue Growth Rate in Dysplasia Epiphysealis Hemimelica Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の子宮頸部異形成診断市場規模・現状・予測（2021年-2027年）

Global Cervical Dysplasia Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-3998 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、子宮頸部異形成診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断テスト、診断装置）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の気管支肺異形成症（BPD）疫学市場規模・現状・予測（2021年-2027年）

Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size, Status and Forecast 2021-2027
QFJ1-3945 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、気管支肺異形成症（BPD）疫学の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステロイド、界面活性剤、気管支拡張薬、ビタミンA、メチルキサンチン、利尿薬、抗生物質）、用途別市場規模（病院、薬局、研究所...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の整形外科関節置換術市場規模・現状・予測（2021年-2027年） Orthopedic Joint Replacement is a procedure of orthopedic surgery in which an arthritic or dysfunctional joint surface is replaced with an orthopedic prosthesis. Market Analysis and Insights: Global Orthopedic Joint Replacement Market The global Orthopedic Joint Replacement market size is projected …
世界の修正膝関節置換術市場規模・現状・予測（2021年-2027年） Revision knee replacement also known as revision total knee arthoplasty, is a procedure in which already implanted artificial knee joint, or prosthesis is replaced with a new prosthesis. Market Analysis and Insights: Global Revision Knee Replacement Market The global Revision Knee Replacement market…
世界の気管支肺異形成症（BPD）疫学市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market The global Bronchopulmonary Dysplasia (BPD) Epidemiology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
世界の子宮頸部異形成診断市場規模・現状・予測（2021年-2027年） Cervical dysplasia, also known as cervical intraepithelial neoplasia (CIN), causes abnormal cell growth that occurs on the epithelial lining of the cervix. Market Analysis and Insights: Global Cervical Dysplasia Diagnostic Market The global Cervical Dysplasia Diagnostic market size is projected to …
世界の関節再建＆置換市場規模・現状・予測（2021年-2027年） Joint Reconstruction includes a variety of therapies, including physical therapy, pain treatment, and surgery. The Joint Replacement part includes partial or complete replacement of artificial or bone graft. Physical therapy is a first-line treatment and is widely used in the primary care of joint d…